8:00 am Registration & Networking Coffee

8:50 am Chair’s Opening Remarks

Overcoming Challenges in Preclinical Assessment & Translation to Accelerate Product Development

10:00 am Challenges in Medical Cannabis Research & Translation to Clinical Practice

Determining the Mechanisms Involved in the Endocannabinoid System and Cannabinoid Receptor Biology

10:30 am Plant-Derived & Endogenous Cannabinoids: Naturally Different

  • Mauro Maccarrone Professor & Chair of Biochemistry and Molecular Biology, University of Rome

11:00 am Peripherally Restricted CB1 Receptor Blockers for the Treatment of the Metabolic Syndrome

  • Simon Benita Professor & Chairman, Hebrew University of Jerusalem, BioNanoSim Ltd

11:20 am Speed Networking Break

11:30 am Understanding the Endocannabinoid System and Cannabinoid Receptor Biology

  • Jahan Marcu CSO , International Research Center on Cannabis and Health

12:00 pm Panel Discussion: Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals

12:30 pm Lunch & Networking Break

Overcoming the Regulatory Hurdles to Gain Approval From Governing Bodies

1:30 pm Regulatory Perspectives on Developing Pharmaceutical Cannabinoids in the United States

  • Arnold Lippa CEO and Co-Founder, RespireRx Pharmaceuticals

2:00 pm Rx & Non-Rx Cannabinoids: A Regulatory Framework for Market Access & Product Quality in Healthcare & Selfcare

2:30 pm Panel Discussion: The Industry Approach to Gaining Drug Approval

3:00 pm Networking Break

3:30 pm Panel Discussion: What Targets are Optimal for Different Disease Indications

4:00 pm Intellectual Property Considerations for CDP Pharma

4:30 pm Chair’s Closing Remarks & End of Day One